ZIP14 zinc transporter downregulation and zinc depletion in the development and progression of hepatocellular cancer

Journal of Gastrointestinal Cancer

Volumn 43, Issue 2, 2012, Pages 249-257

  Franklin, Renty B ^a,b   Levy, Bernard A ^a   Zou, Jing ^a   Hanna, Nader ^b,c   Desouki, Mohamed Mokhtar ^d   Bagasra, Omar ^e,f   Johnson, Leslie A ^e,f   Costello, Leslie C ^a,b  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e South Carolina Center for Biotechnology   (United States)

^f CLAFLIN UNIVERSITY   (United States)

Author keywords

Hepatocellular cancer; Zinc; Zinc transporters; ZIP transporters; ZIP14

Indexed keywords

UNCLASSIFIED DRUG; ZINC; ZINC TRANSPORTER; ZIP1 PROTEIN; ZIP14 PROTEIN; ZIP2 PROTEIN; ZIP3 PROTEIN;

ARTICLE; CANCER GROWTH; DISEASE COURSE; DOWN REGULATION; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; PRIORITY JOURNAL; ZINC DEFICIENCY;

CARCINOMA, HEPATOCELLULAR; CATION TRANSPORT PROTEINS; DISEASE PROGRESSION; DOWN-REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; TISSUE ARRAY ANALYSIS; ZINC;

EID: 84863870545     PISSN: 19416628     EISSN: 19416636     Source Type: Journal    
DOI: 10.1007/s12029-011-9269-x     Document Type: Article

References (27)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
2. Danielsen A, Steinnes E. A study of some selected trace elements in normal and cancerous tissue by neutron activation analysis. J Nucl Med. 1970;11:260-4.
3. Ebara M, Fukuda H, Hatano R, Saisho H, Nagato Y, et al. Relationship between copper, zinc and metallothionein in hepatocellular carcinoma and its surrounding liver parenchyma. J Hepatol. 2000;33:415-22. (Pubitemid 30663379)
4. Liaw KY, Lee PH, Wu FC, Tsai JS, Lin-Shiau SY. Zinc, copper, and superoxide dismutase in hepatocellular carcinoma. Am J Gastroenterol. 1997;92:2260-3.
5. Tashiro H, Kawamoto T, Okubo T, Koide O. Variation in the distribution of trace elements in hepatoma. Biol Trace Elem Res. 2003;95:49-63. (Pubitemid 37386647)
6. Tashiro-Itoh T, Ichida T, Matsuda Y, Satoh T, Sugiyama M, et al. Metallothionein expression and concentrations of copper and zinc are associated with tumor differentiation in hepatocellular carcinoma. Liver. 1997;17:300-6. (Pubitemid 28014679)
7. Gurusamy K, Davidson BR. Trace element concentration in metastatic liver disease: a systematic review. J Trace Elem Med Biol. 2007;21:169-77. (Pubitemid 47241217)
8. Al-Ebraheem A, Farquharson MJ, Ryan E. The evaluation of biologically important trace metals in liver, kidney and breast tissue. Appl Radiat Isot. 2009;67:470-4.
9. Sternberg CA, Philips FS. Histochemical demonstration of zinc in the dorsolaterl prostate of the rat:studies with oxine and dithizone. Am J Pathol. 1965;47:325-37.
10. Franklin RB, Feng P, Milon BC, Desouki MM, Singh KK, et al. hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer. Mol Cancer. 2005. doi:10.1186/1476-4598-4-32.
11. Johnson LA, Kanak MA, Kajdacsy-Balla A, Pestaner JP, Bagasra O. Differential zinc accumulation and expression of human zinc transporter 1 (hZIP1) in prostate glands. Methods. 2010;52:316-21.
12. Desouki MM, Geradts J, Milon B, Franklin RB, Costello LC, et al. hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands. Mol Cancer. 2007. doi:10.1186/1476-4598-6-37.
13. Lipman TO, Diamond A, Mellow MH, Patterson KY. Esophageal zinc content in human squamous esophageal cancer. J Am Coll Nutr:. 1987;6:41-6. (Pubitemid 18053365)
14. Taylor KM, Morgan HE, Johnson A, et al. Structure-function analysis of a novel member of the LIV-1 subfamily of zinc transporters, ZIP14. FEBS Lett. 2005;579:427-32. (Pubitemid 40092422)
15. Lichten LA, Cousins RJ. Interleukin-1beta contributes via nitric oxide to the upregulation and functional activity of the zinc transporter Zip14 (Slc39a14) in murine hepatocytes. Ann Rev Nutr. 2009;29:153-76.
16. Liuzzi JP, Cousins RJ. Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Ann Rev Nutr. 2004;24:151-72.
17. Franklin RB, Costello LC. Zinc as an anti-tumor agent in prostate cancer and in other cancers. Arch Biochem Biophys. 2007;463:211-7. (Pubitemid 47030335)
18. Costello LC, Franklin RB. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer. 2006. doi:10.1186/1476-4598-5-17.
19. Lemire J, Mailloux R, Appanna VD. Zinc toxicity alters mitochondrial metabolism and leads to decreased ATP production in hepatocytes. J Appl Toxicol. 2008;28:175-82. (Pubitemid 351436265)
20. Ohashi T, Matsui T, Chujo M, Nagao M. Restraint stress upregulates expression of zinc transporter Zip14 mRNA in mouse liver. Cytotech. 2008;57:181-5.
21. Weaver BP, Zhang Y, Hiscox S, Guo GL, Apte U, et al. Zip4 (Slc39a4) expression is activated in hepatocellular carcinomas and functions to repress apoptosis, enhance cell cycle and increase migration. PLoS One. 2010. doi:10.1371/journal.pone.0013158.
22. Costello LC, Franklin RB. Metabolic transformations of malignant cells: an overview. In: Hyatt MA, editor. Methods of cancer diagnosis, therapy, and prognosis, vol 2 general methods and overviews, lung carcinoma and prostate carcinoma. New York: Springer; 2008. p. 3-16.
23. Costello LC, Franklin RB. Integration of genetic, proteomic, and metabolic approaches in tumor cell metabolism. In: Singh KK, Costello LC, editors. Mitochondria and Cancer. New York: Springer; 2009. p. 79-92.
24. Anthony PP, Cl V, Barker LF. Liver cell dysplasia: a premalignant condition. J Clin Pathol. 1973;26:217-23.
25. Koo JS, Kim H, Park BK, Ahn SH, Han KH, et al. Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with chronic hepatitis B. J Clin Gastroenterol. 2008;42:738-43.
26. Le Bail B, Bernard PH, Carles J, Ahn SH, Han KH, et al. Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants. J Hepatol. 1997;27:835-42. (Pubitemid 27454827)
27. Podda M, Roncalli M, Battezzati PM, Borzio M, Bruno S, et al. Liver-cell dysplasia and hepatocellular carcinoma. Ital J Gastroenterol. 1992;24:39-42.